Clinical

Dataset Information

0

A retrospective observational study of trifluridine tipiracil plus minus bevacizumab in pretreated mCRC patients with MSI-H MMR-D metastatic colorectal cancer


ABSTRACT: Primary outcome(s): progression free survival time to treatment failure objective response rate disease control rate overall survival

DISEASE(S): Metastatic Colorectal Cancer With Microsatellite Instability High (msi-h) Mismatch Repair Deficient (mmr-d)

PROVIDER: 112360 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| S-EPMC8658167 | biostudies-literature
| S-EPMC8447873 | biostudies-literature